SCHEMBL10084240

SCHEMBL10084240

CCC(=O)NCCC[C@H](N)C(=O)N[C@@H](CCc1ccccc1)C(=O)Nc1cnc2ccccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 8/20 0.49
HDAC4 P56524 7/20 0.49
HDAC6 Q9UBN7 7/20 0.49
HDAC3 O15379 6/20 0.49
HDAC7 Q8WUI4 6/20 0.49
HDAC2 Q92769 6/20 0.49
HDAC10 Q969S8 6/20 0.49
HDAC11 Q96DB2 6/20 0.49
HDAC8 Q9BY41 6/20 0.49
HDAC9 Q9UKV0 6/20 0.49
HDAC5 Q9UQL6 6/20 0.49
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TRPV1 Q8NER1 6/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10084307 1.00 HDAC1 (0.49) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL1246013 0.90 KDM4E (0.46) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL1246018 0.90 KDM4E (0.46) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL12890836 0.90 KDM4E (0.46) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL1244246 0.90 KDM4E (0.46) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL14036070 0.88 HDAC1 (0.45) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL14036069 0.88 HDAC1 (0.45) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL14035987 0.87 HDAC1 (0.46) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL1245989 0.87 HDAC1 (0.50) HDAC1HDAC4HDAC6HDAC3HDAC7
SCHEMBL1244303 0.87 HDAC1 (0.49) HDAC1HDAC4HDAC6HDAC3HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268865-B2 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2012-09-18 US disclosed
US-20120165276-A1 QUATERNARY ALKYL AMMONIUM BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165276-A1 QUATERNARY ALKYL AMMONIUM BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF ABCB11, ABCC1, SLC47A1 HDAC1 333/4885HDAC4 470/4885HDAC6 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.